Kaken Pharmaceutical Co (4521) Q2 2024 Earnings Report

0 Followers

JP:4521 Q2 2024 EPS Results

Actual EPS¥330.91

Consensus EPS―

Beat/Miss―

One Year Ago EPS¥41.19

Actual Revenue¥33.12B

Expected Revenue―

Beat/Miss―

YoY Revenue Growth+83.77%

QuarterQ2 2024

Date11/08/2024

TimeTBA

Conference CallFriday, November 8, 2024

JP:4521 Upcoming Earnings

Kaken Pharmaceutical Co's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q2)	- / -	19.03	―
Aug 07, 2026	2026 (Q1)	- / 222.86	7.13	3025.67% (+215.73)
May 13, 2026	2025 (Q4)	19.98 / 19.70	-140.89	113.98% (+160.59)
Feb 06, 2026	2025 (Q3)	24.79 / 10.71	129.08	-91.70% (-118.37)
Nov 10, 2025	2025 (Q2)	- / 19.03	330.91	-94.25% (-311.88)
Aug 07, 2025	2025 (Q1)	- / 7.13	46.32	-84.61% (-39.19)
May 12, 2025	2024 (Q4)	- / -140.89	35.648	-495.23% (-176.54)
Feb 06, 2025	2024 (Q3)	- / 129.08	68.92	87.29% (+60.16)
Nov 08, 2024	2024 (Q2)	- / 330.91	41.19	703.37% (+289.72)
Aug 07, 2024	2024 (Q1)	- / 46.32	66.99	-30.86% (-20.67)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed